Nvidia disclosed in recent regulatory filings that it had fully exited its roughly two‑year, 7.71 million‑share investment in Recursion Pharmaceuticals, while Cathie Wood’s ARK Invest simultaneously ...

Lana Del Rey kept things light and whimsical in the music video for her latest single, “White Feather Hawk Tail Deer Hunter.” The clip has the feel of home video footage as it follows the artist from ...

“Whoopsie daisy! Yoo-hoo!” Lana Del Rey is back, all right. The singer-songwriter has officially returned with “White Feather Hawk Tail Deer Hunter,” off her upcoming album, Stove. “White Feather Hawk ...

Recursive language models (RLMs) are an inference technique developed by researchers at MIT CSAIL that treat long prompts as an external environment to the model. Instead of forcing the entire prompt ...

No Tail To Tell, the new Korean rom-com on Netflix, involves a lot of mysticism interacting with the real world in the current day. Given the history of romantic K-dramas, though, it doesn’t seem like ...

Science Saru will return with a third season of “Dan Da Dan” airing in 2027, the studio revealed during Jump Festa 2026 on Dec. 21, revealing a new key visual for the supernatural comedy series. The ...

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

FBI Deputy Director Dan Bongino is leaving the bureau in January after speculation rose this week concerning his departure. "I will be leaving my position with the FBI in January," Bongino wrote in an ...

Recursion Pharmaceuticals Inc (NASDAQ: RXRX) shares moved higher Wednesday after JPMorgan upgraded the stock to Overweight from Neutral and lifted its price target to $11 from $10. What Happened: ...

Deputy FBI director Dan Bongino is stepping down soon from the job after eight months marked by clashes with his boss, Attorney General Pamela Bondi, and fighting off the conspiracies he once fueled.

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...